Clinical Trial Update: Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating long-term safety, tolerability and efficacy of perampanel in Parkinson's disease with motor fluctuations was terminated. Results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Parkinson's Disease | Phase 2 | Status: TERMINATED | Results posted: 2013-02-05